Interference with ER-α enhances the therapeutic efficacy of the selective CDK inhibitor roscovitine towards ER-positive breast cancer cells.
about
Inhibition of E2F1/CDK1 pathway attenuates neuronal apoptosis in vitro and confers neuroprotection after spinal cord injury in vivoThe impact of CDK inhibition in human malignancies associated with pronounced defects in apoptosis: advantages of multi-targeting small molecules.Tamoxifen non-estrogen receptor mediated molecular targets.The impact of multi-targeted cyclin-dependent kinase inhibition in breast cancer cells: clinical implications.Natural Compounds as Modulators of Cell Cycle Arrest: Application for Anticancer Chemotherapies.The cyclin-dependent kinase inhibitor roscovitine inhibits kinase activity, cell proliferation, multicellular development, and Cdk5 nuclear translocation in Dictyostelium discoideum.
P2860
Interference with ER-α enhances the therapeutic efficacy of the selective CDK inhibitor roscovitine towards ER-positive breast cancer cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Interference with ER-α enhance ...... -positive breast cancer cells.
@en
Interference with ER-α enhance ...... -positive breast cancer cells.
@nl
type
label
Interference with ER-α enhance ...... -positive breast cancer cells.
@en
Interference with ER-α enhance ...... -positive breast cancer cells.
@nl
prefLabel
Interference with ER-α enhance ...... -positive breast cancer cells.
@en
Interference with ER-α enhance ...... -positive breast cancer cells.
@nl
P2093
P2860
P356
P1476
Interference with ER-α enhance ...... -positive breast cancer cells.
@en
P2093
David Gritsch
Józefa Węsierska-Gądek
Margarita Maurer
Nora Zulehner
Oxana Komina
P2860
P304
P356
10.1002/JCB.23024
P577
2011-04-01T00:00:00Z